Mahana Therapeutics Signs Agreement with Consumer Health Division of Bayer to Commercialize Digital TherapeuticsBusiness Wire • 08/22/23
Bayer and Luke Bryan Reunite for Annual #HerestotheFarmer Campaign in Support of Feeding America and Rural CommunitiesBusiness Wire • 06/28/23
Bayer initiates Phase III studies with investigational contrast agent gadoquatraneBusiness Wire • 06/27/23
FDA approves Bayer's Ultravist® (iopromide) injection for contrast-enhanced mammographyBusiness Wire • 06/23/23
Bayer to Investigate Finerenone in Phase III Study in Adults With Chronic Kidney Disease Associated With Type 1 DiabetesBusiness Wire • 06/22/23
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas TherapeuticsBusiness Wire • 06/06/23